<?xml version="1.0" encoding="UTF-8"?>
<fig id="viruses-04-01950-f004" position="anchor">
 <label>Figure 4</label>
 <caption>
  <p>Comparison of injection intensities in the Central African campaigns (first three categories) and relevant modern populations (remaining categories). (ani): annual number of injections; (anns): annual number of needle shares. The seven categories, from left to right, are as follows: (
   <bold>i</bold>) to (
   <bold>iii</bold>) Central African data, based on our review (
   <xref ref-type="table" rid="viruses-04-01950-t001">Table 1</xref> and 
   <xref ref-type="table" rid="viruses-04-01950-t002">Table 2</xref>); (
   <bold>iv</bold>) available estimates for nosocomial outbreaks (sources: [
   <xref ref-type="bibr" rid="B123-viruses-04-01950">123</xref>,
   <xref ref-type="bibr" rid="B124-viruses-04-01950">124</xref>]); (
   <bold>v</bold>) estimates of needle sharing for IDU groups in which HIV-1 prevalence was either &lt;5% or stagnant since many years previous to observation (sources: [
   <xref ref-type="bibr" rid="B129-viruses-04-01950">129</xref>,
   <xref ref-type="bibr" rid="B130-viruses-04-01950">130</xref>,
   <xref ref-type="bibr" rid="B135-viruses-04-01950">135</xref>,
   <xref ref-type="bibr" rid="B138-viruses-04-01950">138</xref>,
   <xref ref-type="bibr" rid="B139-viruses-04-01950">139</xref>,
   <xref ref-type="bibr" rid="B140-viruses-04-01950">140</xref>]); (
   <bold>vi</bold>) estimates of needle sharing for IDU groups in which HIV-1 prevalence was &gt;10%, had risen fast in previous years, and the study could observe needle sharing rate at the onset of a needle exchanging program, methadone, or other intervention (known to cause dramatic drops in needle sharing) (sources: [
   <xref ref-type="bibr" rid="B125-viruses-04-01950">125</xref>,
   <xref ref-type="bibr" rid="B128-viruses-04-01950">128</xref>,
   <xref ref-type="bibr" rid="B131-viruses-04-01950">131</xref>,
   <xref ref-type="bibr" rid="B132-viruses-04-01950">132</xref>,
   <xref ref-type="bibr" rid="B133-viruses-04-01950">133</xref>,
   <xref ref-type="bibr" rid="B136-viruses-04-01950">136</xref>,
   <xref ref-type="bibr" rid="B137-viruses-04-01950">137</xref>]); (
   <bold>vii</bold>) estimates of annual number of injections (with or without sharing) for IDUs (sources: [
   <xref ref-type="bibr" rid="B125-viruses-04-01950">125</xref>,
   <xref ref-type="bibr" rid="B126-viruses-04-01950">126</xref>,
   <xref ref-type="bibr" rid="B127-viruses-04-01950">127</xref>,
   <xref ref-type="bibr" rid="B128-viruses-04-01950">128</xref>,
   <xref ref-type="bibr" rid="B129-viruses-04-01950">129</xref>,
   <xref ref-type="bibr" rid="B130-viruses-04-01950">130</xref>,
   <xref ref-type="bibr" rid="B131-viruses-04-01950">131</xref>,
   <xref ref-type="bibr" rid="B140-viruses-04-01950">140</xref>]). For each category, the range and average between studies are shown.
  </p>
 </caption>
 <graphic xlink:href="viruses-04-01950-g004" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
